.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Argus Health
Fuji
Harvard Business School
Chinese Patent Office
Queensland Health
Accenture
Deloitte
AstraZeneca

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022439

« Back to Dashboard

NDA 022439 describes ZUTRIPRO, which is a drug marketed by Cypress Pharm and is included in one NDA. It is available from two suppliers. Additional details are available on the ZUTRIPRO profile page.

The generic ingredient in ZUTRIPRO is chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride profile page.

Summary for 022439

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022439

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZUTRIPRO chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride SOLUTION;ORAL 022439 NDA Cypress Pharmaceutical, Inc. 60258-876 60258-876-16 480 mL in 1 BOTTLE (60258-876-16)
ZUTRIPRO chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride SOLUTION;ORAL 022439 NDA Hawthorn Pharmaceuticals, Inc. 63717-876 63717-876-16 480 mL in 1 BOTTLE (63717-876-16)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength4MG/5ML;5MG/5ML;60MG/5ML
Approval Date:Jun 8, 2011TE:AARLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Covington
UBS
Chinese Patent Office
Medtronic
Queensland Health
Novartis
US Army
Harvard Business School
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot